Editas Medicine (EDIT) Accumulated Expenses (2015 - 2025)

Editas Medicine (EDIT) has 11 years of Accumulated Expenses data on file, last reported at $32.6 million in Q4 2025.

• Quarterly Accumulated Expenses fell 28.89% year-over-year to $32.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $32.6 million (down 28.89% YoY) and the FY2025 annual result came in at $32.6 million, down 28.89% from the prior year.
• Accumulated Expenses slipped to $32.6 million in Q4 2025 per EDIT's latest filing, from $47.5 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $48.1 million in Q2 2025 and bottomed at $4.4 million in Q1 2021.
• The 5-year median for Accumulated Expenses is $28.2 million (2024), against an average of $23.9 million.
• The widest annual swing landed in 2021, when Accumulated Expenses slumped 52.53%; it then soared 428.56% in 2024.
• Tracing EDIT's Accumulated Expenses over 5 years: stood at $10.2 million in 2021, then soared by 208.06% to $31.3 million in 2022, then gained by 10.44% to $34.6 million in 2023, then surged by 32.68% to $45.9 million in 2024, then decreased by 28.89% to $32.6 million in 2025.
• Per Business Quant, the three latest EDIT Accumulated Expenses figures stand at $32.6 million (Q4 2025), $47.5 million (Q3 2025), and $48.1 million (Q2 2025).

Peer Comparison